Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study
2023·23 Zitationen·BMC MedicineOpen Access
Volltext beim Verlag öffnen23
Zitationen
29
Autoren
2023
Jahr
Abstract
Chinese Clinical Trial Registry ChiCTR2100048428. Registered on 06 July 2021.
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 28.787 Zit.
TNM Classification of Malignant Tumours
1987 · 16.123 Zit.
A survey on deep learning in medical image analysis
2017 · 13.485 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.734 Zit.
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
2010 · 9.099 Zit.
Autoren
Institutionen
- Guangxi Medical University(CN)
- First Affiliated Hospital of GuangXi Medical University(CN)
- Naval Medical Research Command(US)
- Second Military Medical University(CN)
- Changhai Hospital(CN)
- Nanjing University(CN)
- Nanjing General Hospital of Nanjing Military Command(CN)
- First Affiliated Hospital of Xi'an Jiaotong University(CN)
- Shanghai Ninth People's Hospital(CN)
- Second Affiliated Hospital of Fujian Medical University(CN)
- Fujian Medical University(CN)
- Zhongda Hospital Southeast University(CN)
- First Affiliated Hospital of Soochow University(CN)
- Soochow University(CN)
- Renji Hospital(CN)
- Center for Genomic Science(IT)
Themen
Radiomics and Machine Learning in Medical ImagingAI in cancer detectionArtificial Intelligence in Healthcare and Education